首页 > 最新文献

Clinical Medicine & Research最新文献

英文 中文
Variations in Cancer with Heart Failure Related Mortality in the United States from 1999-2020. 1999-2020年美国癌症合并心力衰竭相关死亡率的变化
IF 1.4 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-11-01 DOI: 10.3121/cmr.2025.2018
Faizan Ahmed, Tehmasp Rehman Mirza, Sherif Eltawansy, Kainat Aman, Satya Rashmit Durugu, Chaitanya Rojulpote, Brijesh Patel

Background: Cancer and heart failure (HF) are significant causes of morbidity and mortality worldwide. Moreover, there is increasing evidence of a relationship between HF and cancer. Although oncology has experienced significant advancements in cancer therapies, patients with a combination of these conditions represent an important clinical challenge due to varying outcomes among different demographic populations. Therefore, understanding these trends is crucial for targeted interventions.Aims: This study analyzed two decades of mortality data to examine the trends, patterns, and disparities in cancer-related and cancer with HF-related deaths across the United States (US).Methods: Mortality data from 1999 to 2020 were obtained using CDC WONDER, identifying cancer and cancer with HF-related deaths in adults age ≥25 years via ICD-10 codes. Demographic and regional distributions of mortality were analyzed utilizing statistical methods. Joinpoint regression analysis was used to determine trends in age-adjusted mortality rates (AAMR) and annual percentage changes (APC).Results: Between 1999 and 2020, there were 13,880,876 cancer-related deaths in the US, including 567,657 with HF listed as a cause of death. The AAMR for cancer-related deaths decreased from 343.7 to 252.4 per 100,000 (APC: -1.61% [95% CI: -1.70, -1.57] from 1999 to 2018, then -0.62% to 2020). Cancer with HF-related deaths initially declined (AAMR: 15.0 to 10.2 from 1999-2013) but increased from 2013 to 2020 (APC: +6.03%). Males had higher mortality rates than females for both conditions. Cancer-related mortality was highest among non-Hispanic (NH) Whites and Hispanics, while cancer with HF-related mortality was highest among NH Whites and NH American Indians/Alaska Natives. Geographically, the South had the most cancer-related deaths (37.3%), while the Midwest led in cancer with HF-related deaths (4.5%).Conclusions: Cancer-related mortality has declined overall, whereas mortality for cancer with co-existing heart failure has risen since 2013 after an initial decline. Disparities persist, with the highest burden in NH Whites, males, and those in rural or underserved areas. The findings underscore the need for focused interventions aimed at reducing mortality related to cancer and cancer with heart failure, particularly among the vulnerable population.

背景:癌症和心力衰竭是世界范围内发病率和死亡率的重要原因。此外,越来越多的证据表明HF与癌症之间存在关联。尽管肿瘤学在癌症治疗方面取得了重大进展,但由于不同人群的预后不同,这些疾病的组合患者代表了一个重要的临床挑战。因此,了解这些趋势对于有针对性的干预措施至关重要。目的:本研究分析了20年的死亡率数据,以检查美国癌症相关和癌症伴hf相关死亡的趋势、模式和差异。方法:使用CDC WONDER获取1999年至2020年的死亡率数据,通过ICD-10代码识别年龄≥25岁的成人中癌症和与hf相关的癌症死亡。采用统计学方法分析死亡率的人口统计学和区域分布。采用联合点回归分析确定年龄调整死亡率(AAMR)和年百分比变化(APC)的趋势。结果:1999年至2020年间,美国有13880876例癌症相关死亡,其中567657例HF列为死亡原因。癌症相关死亡的AAMR从每10万人343.7人下降到252.4人(APC: -1.61% [95% CI: -1.70, -1.57],从1999年到2018年,从-0.62%到2020年)。hf相关死亡的癌症最初下降(1999-2013年AAMR: 15.0至10.2),但从2013年到2020年上升(APC: +6.03%)。在这两种情况下,男性的死亡率都高于女性。癌症相关死亡率在非西班牙裔(NH)白人和西班牙裔中最高,而与hf相关的癌症死亡率在NH白人和NH美洲印第安人/阿拉斯加原住民中最高。从地理上看,南方的癌症相关死亡人数最多(37.3%),而中西部的癌症相关死亡人数最多(4.5%)。结论:癌症相关死亡率总体下降,而癌症合并心力衰竭的死亡率在最初下降后,自2013年以来有所上升。差距仍然存在,以最重的负担在NH白人,男性和那些在农村或服务不足地区。研究结果强调,需要有针对性的干预措施,旨在降低与癌症和癌症合并心力衰竭有关的死亡率,特别是在弱势群体中。
{"title":"Variations in Cancer with Heart Failure Related Mortality in the United States from 1999-2020.","authors":"Faizan Ahmed, Tehmasp Rehman Mirza, Sherif Eltawansy, Kainat Aman, Satya Rashmit Durugu, Chaitanya Rojulpote, Brijesh Patel","doi":"10.3121/cmr.2025.2018","DOIUrl":"10.3121/cmr.2025.2018","url":null,"abstract":"<p><p><b>Background:</b> Cancer and heart failure (HF) are significant causes of morbidity and mortality worldwide. Moreover, there is increasing evidence of a relationship between HF and cancer. Although oncology has experienced significant advancements in cancer therapies, patients with a combination of these conditions represent an important clinical challenge due to varying outcomes among different demographic populations. Therefore, understanding these trends is crucial for targeted interventions.<b>Aims:</b> This study analyzed two decades of mortality data to examine the trends, patterns, and disparities in cancer-related and cancer with HF-related deaths across the United States (US).<b>Methods:</b> Mortality data from 1999 to 2020 were obtained using CDC WONDER, identifying cancer and cancer with HF-related deaths in adults age ≥25 years via ICD-10 codes. Demographic and regional distributions of mortality were analyzed utilizing statistical methods. Joinpoint regression analysis was used to determine trends in age-adjusted mortality rates (AAMR) and annual percentage changes (APC).<b>Results:</b> Between 1999 and 2020, there were 13,880,876 cancer-related deaths in the US, including 567,657 with HF listed as a cause of death. The AAMR for cancer-related deaths decreased from 343.7 to 252.4 per 100,000 (APC: -1.61% [95% CI: -1.70, -1.57] from 1999 to 2018, then -0.62% to 2020). Cancer with HF-related deaths initially declined (AAMR: 15.0 to 10.2 from 1999-2013) but increased from 2013 to 2020 (APC: +6.03%). Males had higher mortality rates than females for both conditions. Cancer-related mortality was highest among non-Hispanic (NH) Whites and Hispanics, while cancer with HF-related mortality was highest among NH Whites and NH American Indians/Alaska Natives. Geographically, the South had the most cancer-related deaths (37.3%), while the Midwest led in cancer with HF-related deaths (4.5%).<b>Conclusions:</b> Cancer-related mortality has declined overall, whereas mortality for cancer with co-existing heart failure has risen since 2013 after an initial decline. Disparities persist, with the highest burden in NH Whites, males, and those in rural or underserved areas. The findings underscore the need for focused interventions aimed at reducing mortality related to cancer and cancer with heart failure, particularly among the vulnerable population.</p>","PeriodicalId":47429,"journal":{"name":"Clinical Medicine & Research","volume":"23 3","pages":"89-96"},"PeriodicalIF":1.4,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12667032/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145597866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eosinophilic Fasciitis after Covid Infection: A Case Report and Review of Literature. 新冠病毒感染后嗜酸性筋膜炎1例报告及文献复习。
IF 1.4 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-08-01 DOI: 10.3121/cmr.2025.1907
Sweta Boban, Hiral Patel, Jonathan Cutlan, Boban Mathew, Lisa Francis

Eosinophilic fasciitis (EF) is a rare fibrosing disorder caused by an autoimmune response to an unknown trigger. Many possible triggers have been suggested including strenuous exercise, drug or chemical exposure, and preceding infection. We present a case of a female patient, age 69 years, who developed EF following SARS-CoV-2 infection. There have been several advances in the diagnosis and management of EF since it was first described 50 years ago. EF is a mimic of scleroderma, but key clinical features can be used to differentiate between the two diagnoses. Laboratory abnormalities include eosinophilia, elevated inflammatory markers, and hypergammaglobulinemia. A full thickness biopsy of the skin including muscle and fascia is recommended to confirm the diagnosis. Imaging modalities such as ultrasound and magnetic resonance imaging have been increasingly used in the diagnosis and follow-up of EF. Corticosteroids remain the first line in treatment of EF. Combination of steroids and methotrexate have shown the best possible outcome. Early diagnosis is important for better treatment response.

嗜酸性筋膜炎(EF)是一种罕见的纤维化疾病,由自身免疫反应引起的未知触发。许多可能的诱因包括剧烈运动、药物或化学物质暴露以及先前的感染。我们报告一例女性患者,年龄69岁,在SARS-CoV-2感染后发生EF。自50年前首次被描述以来,EF的诊断和治疗已经取得了一些进展。EF是一种模拟硬皮病,但关键的临床特征可以用来区分两种诊断。实验室异常包括嗜酸性粒细胞增多、炎症标志物升高和高γ -球蛋白血症。建议对包括肌肉和筋膜在内的皮肤进行全层活检以确认诊断。超声和磁共振成像等影像学手段越来越多地应用于EF的诊断和随访。皮质类固醇仍然是治疗EF的一线药物。类固醇和甲氨蝶呤的组合显示出最好的可能结果。早期诊断对更好的治疗效果很重要。
{"title":"Eosinophilic Fasciitis after Covid Infection: A Case Report and Review of Literature.","authors":"Sweta Boban, Hiral Patel, Jonathan Cutlan, Boban Mathew, Lisa Francis","doi":"10.3121/cmr.2025.1907","DOIUrl":"10.3121/cmr.2025.1907","url":null,"abstract":"<p><p>Eosinophilic fasciitis (EF) is a rare fibrosing disorder caused by an autoimmune response to an unknown trigger. Many possible triggers have been suggested including strenuous exercise, drug or chemical exposure, and preceding infection. We present a case of a female patient, age 69 years, who developed EF following SARS-CoV-2 infection. There have been several advances in the diagnosis and management of EF since it was first described 50 years ago. EF is a mimic of scleroderma, but key clinical features can be used to differentiate between the two diagnoses. Laboratory abnormalities include eosinophilia, elevated inflammatory markers, and hypergammaglobulinemia. A full thickness biopsy of the skin including muscle and fascia is recommended to confirm the diagnosis. Imaging modalities such as ultrasound and magnetic resonance imaging have been increasingly used in the diagnosis and follow-up of EF. Corticosteroids remain the first line in treatment of EF. Combination of steroids and methotrexate have shown the best possible outcome. Early diagnosis is important for better treatment response.</p>","PeriodicalId":47429,"journal":{"name":"Clinical Medicine & Research","volume":"23 2","pages":"67-71"},"PeriodicalIF":1.4,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12352912/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144856751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impaired Sustained Attention in Patients with Subclinical Hypothyroidism. 亚临床甲状腺功能减退患者持续注意力受损。
IF 1.4 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-08-01 DOI: 10.3121/cmr.2025.1925
Satkarjit Kaur Jhandi, Shweta Shenoy, Ajaypal Singh Randhawa, A P Singh

Background: Subclinical hypothyroidism (SCH) is of particular importance due to its high prevalence and its association with cognitive deficits. Patients often express complaints of neuropsychological symptoms and cognitive impairments including lack of attention. Also, patients treated with levothyroxine (LT-4) often report persistent complaints related to mental slowing or lack of attention despite normal TSH levels.Purpose: To investigate the effects of different ranges of TSH on sustained attention in SCH.Methods: Included in the study were 136 participants that were divided into four groups: Group 1, 35 healthy individuals; Group 2, 33 newly diagnosed patients with SCH; Group 3, 36 patients on LT-4 with uncontrolled or elevated TSH; Group 4, 32 euthyroid patients (ongoing LT-4). Laboratory measurements and clinical assessment were done. Rapid visual processing (RVP) task was performed on standardized battery (Cambridge Automated Neuropsychological Test Battery).Results: There was significant impairment in sustained attention (P=<0.05) in Group 2 patients who had neuropsychological symptoms and SCH diagnosed with a TSH range of ≥2.5mIU/L.Conclusion: Our findings encourage screening for sustained attention along with thyroid profile in those who report neuropsychological symptoms. TSH mean range of ≥2.5 mIU/L was established as a more reasonable threshold for evaluating sustained attention and initiating LT-4 in SCH.

背景:亚临床甲状腺功能减退症(SCH)由于其高患病率及其与认知缺陷的关联而特别重要。患者经常表现出神经心理症状和认知障碍,包括缺乏注意力。此外,接受左旋甲状腺素(LT-4)治疗的患者经常报告持续的与精神迟钝或缺乏注意力相关的抱怨,尽管TSH水平正常。目的:探讨不同TSH水平对schh患者持续注意的影响。方法:将136名被试分为4组:1组35名健康个体;第二组,新诊断SCH患者33例;第三组,36例接受LT-4治疗且TSH升高或未控制的患者;第4组,32例甲状腺功能正常患者(正在进行LT-4)。进行了实验室测量和临床评估。快速视觉处理(RVP)任务采用标准化电池(剑桥自动神经心理测试电池)完成。结果:持续注意力明显受损(P=结论:我们的研究结果鼓励对报告神经心理症状的患者进行持续注意力和甲状腺特征的筛查。TSH平均值≥2.5 mIU/L被确定为评估SCH持续注意和启动LT-4的更合理阈值。
{"title":"Impaired Sustained Attention in Patients with Subclinical Hypothyroidism.","authors":"Satkarjit Kaur Jhandi, Shweta Shenoy, Ajaypal Singh Randhawa, A P Singh","doi":"10.3121/cmr.2025.1925","DOIUrl":"10.3121/cmr.2025.1925","url":null,"abstract":"<p><p><b>Background:</b> Subclinical hypothyroidism (SCH) is of particular importance due to its high prevalence and its association with cognitive deficits. Patients often express complaints of neuropsychological symptoms and cognitive impairments including lack of attention. Also, patients treated with levothyroxine (LT-4) often report persistent complaints related to mental slowing or lack of attention despite normal TSH levels.<b>Purpose:</b> To investigate the effects of different ranges of TSH on sustained attention in SCH.<b>Methods:</b> Included in the study were 136 participants that were divided into four groups: Group 1, 35 healthy individuals; Group 2, 33 newly diagnosed patients with SCH; Group 3, 36 patients on LT-4 with uncontrolled or elevated TSH; Group 4, 32 euthyroid patients (ongoing LT-4). Laboratory measurements and clinical assessment were done. Rapid visual processing (RVP) task was performed on standardized battery (Cambridge Automated Neuropsychological Test Battery).<b>Results:</b> There was significant impairment in sustained attention (<i>P</i>=<0.05) in Group 2 patients who had neuropsychological symptoms and SCH diagnosed with a TSH range of ≥2.5mIU/L.<b>Conclusion:</b> Our findings encourage screening for sustained attention along with thyroid profile in those who report neuropsychological symptoms. TSH mean range of ≥2.5 mIU/L was established as a more reasonable threshold for evaluating sustained attention and initiating LT-4 in SCH.</p>","PeriodicalId":47429,"journal":{"name":"Clinical Medicine & Research","volume":"23 2","pages":"45-52"},"PeriodicalIF":1.4,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12352913/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144856752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low HDL-The Challenge. 低高密度脂蛋白-挑战。
IF 1.4 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-08-01 DOI: 10.3121/cmr.2025.1970
Shereif H Rezkalla, Robert A Kloner

The main function of high-density lipoprotein (HDL) is to remove low-density lipoprotein (LDL) from blood vessels through reverse cholesterol transport. In addition, HDL has anti-inflammatory and antioxidant properties. Low HDL level is an independent risk factor for development of coronary artery disease. To manage patients with low HDL levels, general measures such as lifestyle modification, controlling acute metabolic syndrome, and participating in regular endurance exercise are essential. Smoking cessation is a must, and it will often improve HDL levels by 5% to 10%. While statin therapy is the backbone therapy for controlling LDL levels, it also results in elevation of HDL levels by at least 5%. Specific pharmacologic interventions to improve HDL level and function have been disappointing. Cholesteryl ester transfer protein (CETP) is the key metabolic pathway to transfer HDL to LDL; thus, CETP inhibitors result in elevation of HDL levels. Several products were tested in large controlled studies, such as dalcetrapib and evacetrapib; neither resulted in any clinical benefit. Anacetrapib only resulted in very limited benefit and is no longer under active development. The most recent study utilized apolipoprotein A1 infusion in high-risk patients shortly after acute myocardial infarction. There was no benefit in the primary end point of myocardial infarction, stroke, or death. In patients with low HDL, a strategy of having LDL as low as can be possibly achieved may be the most appropriate approach.

高密度脂蛋白(HDL)的主要功能是通过逆向胆固醇转运将低密度脂蛋白(LDL)从血管中清除。此外,HDL具有抗炎和抗氧化特性。低HDL水平是冠状动脉疾病发展的独立危险因素。对于低HDL水平的患者,一般的措施,如生活方式的改变,控制急性代谢综合征,参加定期耐力运动是必不可少的。戒烟是必须的,它通常会使高密度脂蛋白水平提高5%到10%。虽然他汀类药物治疗是控制LDL水平的主要治疗方法,但它也会导致HDL水平升高至少5%。改善HDL水平和功能的特定药物干预一直令人失望。胆固醇酯转移蛋白(CETP)是将HDL转化为LDL的关键代谢途径;因此,CETP抑制剂导致HDL水平升高。一些产品在大型对照研究中进行了测试,如dalcetrapib和evacetrapib;这两项研究都没有产生任何临床益处。Anacetrapib仅产生非常有限的益处,不再处于积极开发中。最近的研究利用载脂蛋白A1输注在高危患者急性心肌梗死后不久。在心肌梗死、中风或死亡的主要终点没有获益。对于低HDL患者,尽可能降低LDL可能是最合适的方法。
{"title":"Low HDL-The Challenge.","authors":"Shereif H Rezkalla, Robert A Kloner","doi":"10.3121/cmr.2025.1970","DOIUrl":"10.3121/cmr.2025.1970","url":null,"abstract":"<p><p>The main function of high-density lipoprotein (HDL) is to remove low-density lipoprotein (LDL) from blood vessels through reverse cholesterol transport. In addition, HDL has anti-inflammatory and antioxidant properties. Low HDL level is an independent risk factor for development of coronary artery disease. To manage patients with low HDL levels, general measures such as lifestyle modification, controlling acute metabolic syndrome, and participating in regular endurance exercise are essential. Smoking cessation is a must, and it will often improve HDL levels by 5% to 10%. While statin therapy is the backbone therapy for controlling LDL levels, it also results in elevation of HDL levels by at least 5%. Specific pharmacologic interventions to improve HDL level and function have been disappointing. Cholesteryl ester transfer protein (CETP) is the key metabolic pathway to transfer HDL to LDL; thus, CETP inhibitors result in elevation of HDL levels. Several products were tested in large controlled studies, such as dalcetrapib and evacetrapib; neither resulted in any clinical benefit. Anacetrapib only resulted in very limited benefit and is no longer under active development. The most recent study utilized apolipoprotein A1 infusion in high-risk patients shortly after acute myocardial infarction. There was no benefit in the primary end point of myocardial infarction, stroke, or death. In patients with low HDL, a strategy of having LDL as low as can be possibly achieved may be the most appropriate approach.</p>","PeriodicalId":47429,"journal":{"name":"Clinical Medicine & Research","volume":"23 2","pages":"60-66"},"PeriodicalIF":1.4,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12352915/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144856753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-equivalence of Standard and Unified Criteria for Gestational Diabetes Mellitus. 妊娠期糖尿病标准与统一标准的不等同性。
IF 1.4 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-08-01 DOI: 10.3121/cmr.2025.1974
Ahmad Hamdan, Amna Zar, Fatima R Alsharif, Mohannad N AbuHaweeleh, Nouran Alwisi, Hanan Khudadad, Khalid Bashir, Stephen Beer, Mohammed Bashir, Abdul-Badi Abou-Samra, Suhail A R Doi

Objective: There are two types of criteria for diagnosing gestational diabetes mellitus (GDM). The first is based on measurement of three values on the glucose tolerance test (GTT) and making a diagnosis when any value is abnormal (individual time-point criterion). The second is based on creating a weighted average of the three values and using the average to split glycemic status into normal gestational glycemia (NGG), impaired gestational glycemia (IGG), gestational diabetes (GDM), or high-risk gestational diabetes (hGDM) (unified criterion). There is no information currently regarding how these two criteria relate to each other in the diagnosis of GDM. This study aimed to make this comparison.Design: Cross-sectional study.Setting: Publicly available data on a cohort of women in pregnancy.Participants: Pregnant women from the cohort.Methods: The cross-classification of diagnosis by two criteria was evaluated. The individual time-point criterion had a binary outcome (GDM yes/no), while the unified criterion had the four aforementioned outcomes.Results: Within the low risk (non-GDM) category by the individual time-point criterion, 1 in 85 women would have been deemed at high risk by the unified criterion. More importantly, within the high risk (GDM) category by the individual time-point criterion, 1 in 2 women would have been deemed at low risk by the unified criterion.Conclusion: The standard criterion is not equivalent to the unified criterion in terms of risk estimation. This is important as the unified criterion correlates with area under the GTT curve known to be associated with glucose excursion and is predictive of the net effect of insulin resistance and beta-cell function.

目的:诊断妊娠期糖尿病(GDM)有两种标准。第一种是基于葡萄糖耐量试验(GTT)的三个值的测量,当任何值异常时做出诊断(个体时间点标准)。第二种方法是建立三个值的加权平均值,并使用平均值将血糖状态分为正常妊娠血糖(NGG),妊娠血糖受损(IGG),妊娠糖尿病(GDM)或高危妊娠糖尿病(hGDM)(统一标准)。目前还没有关于这两个标准在GDM诊断中的相互关系的信息。本研究旨在进行这种比较。设计:横断面研究。背景:一组孕期妇女的公开数据。参与者:队列中的孕妇。方法:对两种诊断标准的交叉分类进行评价。单个时间点标准有一个二元结果(GDM是/否),而统一标准有上述四个结果。结果:根据个体时间点标准,在低风险(非gdm)类别中,按照统一标准,85名女性中有1名被视为高风险。更重要的是,根据个人时间点标准,在高风险(GDM)类别中,根据统一标准,每2名女性中就有1名被视为低风险。结论:在风险评价方面,标准准则不等同于统一准则。这一点很重要,因为统一的标准与已知与葡萄糖漂移相关的GTT曲线下的面积相关,并且可以预测胰岛素抵抗和β细胞功能的净效应。
{"title":"Non-equivalence of Standard and Unified Criteria for Gestational Diabetes Mellitus.","authors":"Ahmad Hamdan, Amna Zar, Fatima R Alsharif, Mohannad N AbuHaweeleh, Nouran Alwisi, Hanan Khudadad, Khalid Bashir, Stephen Beer, Mohammed Bashir, Abdul-Badi Abou-Samra, Suhail A R Doi","doi":"10.3121/cmr.2025.1974","DOIUrl":"10.3121/cmr.2025.1974","url":null,"abstract":"<p><p><b>Objective:</b> There are two types of criteria for diagnosing gestational diabetes mellitus (GDM). The first is based on measurement of three values on the glucose tolerance test (GTT) and making a diagnosis when any value is abnormal (individual time-point criterion). The second is based on creating a weighted average of the three values and using the average to split glycemic status into normal gestational glycemia (NGG), impaired gestational glycemia (IGG), gestational diabetes (GDM), or high-risk gestational diabetes (hGDM) (unified criterion). There is no information currently regarding how these two criteria relate to each other in the diagnosis of GDM. This study aimed to make this comparison.<b>Design:</b> Cross-sectional study.<b>Setting:</b> Publicly available data on a cohort of women in pregnancy.<b>Participants:</b> Pregnant women from the cohort.<b>Methods:</b> The cross-classification of diagnosis by two criteria was evaluated. The individual time-point criterion had a binary outcome (GDM yes/no), while the unified criterion had the four aforementioned outcomes.<b>Results:</b> Within the low risk (non-GDM) category by the individual time-point criterion, 1 in 85 women would have been deemed at high risk by the unified criterion. More importantly, within the high risk (GDM) category by the individual time-point criterion, 1 in 2 women would have been deemed at low risk by the unified criterion.<b>Conclusion:</b> The standard criterion is not equivalent to the unified criterion in terms of risk estimation. This is important as the unified criterion correlates with area under the GTT curve known to be associated with glucose excursion and is predictive of the net effect of insulin resistance and beta-cell function.</p>","PeriodicalId":47429,"journal":{"name":"Clinical Medicine & Research","volume":"23 2","pages":"53-59"},"PeriodicalIF":1.4,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12352914/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144856754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complex Separation Humeral Head Fracture in a Young Patient: Operative and Postoperative Challenges. 一例年轻患者复杂分离肱骨头骨折:手术和术后的挑战。
IF 1.4 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-08-01 DOI: 10.3121/cmr.2025.1987
Evangelos Sakellariou, Athanasios Galanis, Evangelia Argyropoulou, Michail Vavourakis, Panagiotis Karampinas, Dimitrios Zachariou, Vasilios Marougklianis, Iordanis Varsamos, Dimitrios Kalavrytinos, Eftychios Papagrigorakis

Management of humeral head fractures presents numerous challenges, particularly in cases of separation fractures, which are relatively rare and often caused by high-energy trauma. Due to the complexity of these fractures and the absence of a standardized treatment algorithm, surgical intervention can be technically intricate and fraught with postoperative complications. In young patients, the decision to pursue open reduction and internal fixation must be meticulously made to achieve optimal outcomes while minimizing long-term sequelae. We present a rare case of a man, age 25 years, sustaining a complex proximal humerus fracture. The patient presented with a proximal humerus fracture involving a head-splitting pattern comprising five fragmented pieces, necessitating careful anatomical reduction and fixation. Despite the technical challenges encountered during surgery, including the meticulous reconstruction of the humeral head "puzzle" using headless screws, the postoperative recovery was relatively uneventful. While some restrictions in range of motion were noted postoperatively, the absence of early complications like osteonecrosis bodes well for the patient's long-term functional prognosis. This is a thought-provoking case accentuating that by apposite surgical techniques and tailored treatment strategy to individual young patients, successful management of humeral head fractures can be achieved while minimizing potential complications and optimizing functional recovery in this challenging patient population.

肱骨头骨折的治疗面临许多挑战,特别是在分离性骨折的情况下,这是相对罕见的,通常是由高能创伤引起的。由于这些骨折的复杂性和缺乏标准化的治疗算法,手术干预在技术上可能是复杂的,充满了术后并发症。在年轻患者中,必须谨慎地决定进行切开复位和内固定,以达到最佳结果,同时尽量减少长期后遗症。我们提出一个罕见的情况下,男性,25岁,维持复杂的肱骨近端骨折。患者表现为肱骨近端骨折,包括5个碎片,需要仔细的解剖复位和固定。尽管在手术过程中遇到了技术挑战,包括使用无头螺钉细致地重建肱骨头“谜”,但术后恢复相对平稳。虽然术后注意到一些活动范围的限制,但没有早期并发症,如骨坏死,预示着患者的长期功能预后良好。这是一个发人深省的案例,强调通过适当的手术技术和量身定制的治疗策略,可以成功地治疗肱骨头骨折,同时最大限度地减少潜在的并发症,并优化这一具有挑战性的患者群体的功能恢复。
{"title":"Complex Separation Humeral Head Fracture in a Young Patient: Operative and Postoperative Challenges.","authors":"Evangelos Sakellariou, Athanasios Galanis, Evangelia Argyropoulou, Michail Vavourakis, Panagiotis Karampinas, Dimitrios Zachariou, Vasilios Marougklianis, Iordanis Varsamos, Dimitrios Kalavrytinos, Eftychios Papagrigorakis","doi":"10.3121/cmr.2025.1987","DOIUrl":"10.3121/cmr.2025.1987","url":null,"abstract":"<p><p>Management of humeral head fractures presents numerous challenges, particularly in cases of separation fractures, which are relatively rare and often caused by high-energy trauma. Due to the complexity of these fractures and the absence of a standardized treatment algorithm, surgical intervention can be technically intricate and fraught with postoperative complications. In young patients, the decision to pursue open reduction and internal fixation must be meticulously made to achieve optimal outcomes while minimizing long-term sequelae. We present a rare case of a man, age 25 years, sustaining a complex proximal humerus fracture. The patient presented with a proximal humerus fracture involving a head-splitting pattern comprising five fragmented pieces, necessitating careful anatomical reduction and fixation. Despite the technical challenges encountered during surgery, including the meticulous reconstruction of the humeral head \"puzzle\" using headless screws, the postoperative recovery was relatively uneventful. While some restrictions in range of motion were noted postoperatively, the absence of early complications like osteonecrosis bodes well for the patient's long-term functional prognosis. This is a thought-provoking case accentuating that by apposite surgical techniques and tailored treatment strategy to individual young patients, successful management of humeral head fractures can be achieved while minimizing potential complications and optimizing functional recovery in this challenging patient population.</p>","PeriodicalId":47429,"journal":{"name":"Clinical Medicine & Research","volume":"23 2","pages":"72-78"},"PeriodicalIF":1.4,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12352911/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144856750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PRN Antihypertensives in Hospitals: A Crisis of Precision or Pragmatism? 医院PRN降压药:精准还是实用的危机?
IF 1.2 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-03-01 DOI: 10.3121/cmr.2025.2002
Apurva Popat
{"title":"PRN Antihypertensives in Hospitals: A Crisis of Precision or Pragmatism?","authors":"Apurva Popat","doi":"10.3121/cmr.2025.2002","DOIUrl":"10.3121/cmr.2025.2002","url":null,"abstract":"","PeriodicalId":47429,"journal":{"name":"Clinical Medicine & Research","volume":"23 1","pages":"1-2"},"PeriodicalIF":1.2,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12172660/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144318330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Weil's Disease with Multi-Organ Dysfunction: A Diagnostic Challenge. 伴有多器官功能障碍的韦尔氏病:一个诊断挑战。
IF 1.2 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-03-01 DOI: 10.3121/cmr.2025.1963
David Vivero-Tellez, Joshua Antonio Contreras-Ortíz, Emmanuel Flores-Martínez, Abraham Edgar Gracia-Ramos

Leptospirosis is a zoonotic disease caused by spirochetes from the species Leptospira Weil's disease, the more severe manifestation of leptospirosis, is characterized by a combination of jaundice, renal injury, and hemorrhages. Diagnosing severe leptospirosis in patients with acute life-threatening multi-organ dysfunction at presentation can be challenging because of the non-specific clinical manifestations. This report describes a case of severe leptospirosis with jaundice, acute renal dysfunction, severe thrombocytopenia, pulmonary hemorrhage, and unusual manifestations, including rhabdomyolysis, acalculous cholecystitis, and pancreatitis, which required a comprehensive diagnostic evaluation of possible causes to confirm the diagnosis. The case highlights the importance of clinicians considering leptospirosis in the differential diagnosis of a patient with cryptogenic sepsis who develops multiple organ dysfunction.

钩端螺旋体病是由钩端螺旋体引起的一种人畜共患疾病,钩端螺旋体病是钩端螺旋体病较严重的表现,其特征是黄疸、肾损伤和出血。诊断严重钩端螺旋体病患者急性危及生命的多器官功能障碍的表现可能是具有挑战性的,因为非特异性的临床表现。本报告描述了一例严重钩端螺旋体病伴黄疸、急性肾功能不全、严重血小板减少、肺出血,并有异常表现,包括横纹肌溶解、结石性胆囊炎和胰腺炎,需要对可能的病因进行全面的诊断评估以确认诊断。该病例强调了临床医生考虑钩端螺旋体病在多器官功能障碍的隐源性败血症患者鉴别诊断中的重要性。
{"title":"Weil's Disease with Multi-Organ Dysfunction: A Diagnostic Challenge.","authors":"David Vivero-Tellez, Joshua Antonio Contreras-Ortíz, Emmanuel Flores-Martínez, Abraham Edgar Gracia-Ramos","doi":"10.3121/cmr.2025.1963","DOIUrl":"10.3121/cmr.2025.1963","url":null,"abstract":"<p><p>Leptospirosis is a zoonotic disease caused by spirochetes from the species <i>Leptospira</i> Weil's disease, the more severe manifestation of leptospirosis, is characterized by a combination of jaundice, renal injury, and hemorrhages. Diagnosing severe leptospirosis in patients with acute life-threatening multi-organ dysfunction at presentation can be challenging because of the non-specific clinical manifestations. This report describes a case of severe leptospirosis with jaundice, acute renal dysfunction, severe thrombocytopenia, pulmonary hemorrhage, and unusual manifestations, including rhabdomyolysis, acalculous cholecystitis, and pancreatitis, which required a comprehensive diagnostic evaluation of possible causes to confirm the diagnosis. The case highlights the importance of clinicians considering leptospirosis in the differential diagnosis of a patient with cryptogenic sepsis who develops multiple organ dysfunction.</p>","PeriodicalId":47429,"journal":{"name":"Clinical Medicine & Research","volume":"23 1","pages":"26-31"},"PeriodicalIF":1.2,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12172661/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144318331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
False Positive Supraventricular Tachycardia During Exercise Stress Test. 运动负荷试验中假阳性室上性心动过速。
IF 1.2 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-03-01 DOI: 10.3121/cmr.2025.201
Apurva Popat, Sweta Yadav, Deepa Soodi, Param P Sharma

Exercise stress testing is crucial for assessing myocardial ischemia. However, artifacts from algorithmic interpretation and limitations of linked median algorithms can lead to false-positive findings. A female patient, age 63 years, underwent treadmill stress testing for atypical chest pain. Linked median analysis showed narrow complex tachycardia at 270 bpm during the stress test. Having supraventricular tachycardia (SVT) with a heart rate of 260 bpm would be extremely uncommon in a patient 63 years of age, especially without symptoms. The patient was initially planned for inpatient admission, but the raw electrocardiogram (ECG) confirmed sinus tachycardia. This case emphasizes the need for verification of synthesized ECG to avoid false-positive arrhythmia diagnoses.

运动应激试验是评估心肌缺血的关键。然而,来自算法解释的工件和关联中位数算法的局限性可能导致假阳性结果。一位63岁的女性患者因非典型胸痛接受了跑步机压力测试。相关中位数分析显示,在压力测试期间,狭窄的复杂心动过速为每分钟270次。在63岁的患者中,特别是没有症状的患者,出现心率为260 bpm的室上性心动过速(SVT)是非常罕见的。患者最初计划住院,但原始心电图(ECG)证实窦性心动过速。本病例强调需要对合成心电图进行验证,以避免心律失常的假阳性诊断。
{"title":"False Positive Supraventricular Tachycardia During Exercise Stress Test.","authors":"Apurva Popat, Sweta Yadav, Deepa Soodi, Param P Sharma","doi":"10.3121/cmr.2025.201","DOIUrl":"10.3121/cmr.2025.201","url":null,"abstract":"<p><p>Exercise stress testing is crucial for assessing myocardial ischemia. However, artifacts from algorithmic interpretation and limitations of linked median algorithms can lead to false-positive findings. A female patient, age 63 years, underwent treadmill stress testing for atypical chest pain. Linked median analysis showed narrow complex tachycardia at 270 bpm during the stress test. Having supraventricular tachycardia (SVT) with a heart rate of 260 bpm would be extremely uncommon in a patient 63 years of age, especially without symptoms. The patient was initially planned for inpatient admission, but the raw electrocardiogram (ECG) confirmed sinus tachycardia. This case emphasizes the need for verification of synthesized ECG to avoid false-positive arrhythmia diagnoses.</p>","PeriodicalId":47429,"journal":{"name":"Clinical Medicine & Research","volume":"23 1","pages":"32-36"},"PeriodicalIF":1.2,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12172659/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144318328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case of Methemoglobinemia and Hemolysis from Sodium Chlorite Ingestion. 食入亚氯酸钠致高铁血红蛋白血症及溶血1例。
IF 1.2 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-03-01 DOI: 10.3121/cmr.2025.1954
Jessica Liu, Matthew Patel, Marisa Vigna, Mark Keith Hewitt, Wendy Lim

Sodium chlorite is a household and industrial cleaning agent that can cause oxidative stress leading to methemoglobinemia and severe hemolysis when ingested. There is a scarcity of published literature reporting this in humans. We report a case of intentional sodium chlorite ingestion for homeopathic purposes that resulted in methemoglobinemia and hemolysis, requiring admission to the intensive care unit. Following successful treatment with methylene blue, the patient developed worsening hemolytic activity. Outpatient testing later revealed she was non- glucose-6-phosphate dehydrogenase (G6PD) deficient. Hemolysis precipitated by methylene blue is an underrecognized side effect that can be observed in individuals both with and without G6PD deficiency.

亚氯酸钠是一种家用和工业清洗剂,当摄入时会引起氧化应激,导致高铁血红蛋白血症和严重的溶血。在人类中发表的文献报道很少。我们报告一个顺势疗法的目的故意摄入亚氯酸钠的情况下,导致高铁血红蛋白血症和溶血,需要入院重症监护病房。亚甲蓝治疗成功后,患者溶血活性恶化。门诊检查显示她缺乏非葡萄糖-6-磷酸脱氢酶(G6PD)。亚甲基蓝引起的溶血是一种未被认识到的副作用,在G6PD缺乏症患者和非G6PD缺乏症患者中都可以观察到。
{"title":"A Case of Methemoglobinemia and Hemolysis from Sodium Chlorite Ingestion.","authors":"Jessica Liu, Matthew Patel, Marisa Vigna, Mark Keith Hewitt, Wendy Lim","doi":"10.3121/cmr.2025.1954","DOIUrl":"10.3121/cmr.2025.1954","url":null,"abstract":"<p><p>Sodium chlorite is a household and industrial cleaning agent that can cause oxidative stress leading to methemoglobinemia and severe hemolysis when ingested. There is a scarcity of published literature reporting this in humans. We report a case of intentional sodium chlorite ingestion for homeopathic purposes that resulted in methemoglobinemia and hemolysis, requiring admission to the intensive care unit. Following successful treatment with methylene blue, the patient developed worsening hemolytic activity. Outpatient testing later revealed she was non- glucose-6-phosphate dehydrogenase (G6PD) deficient. Hemolysis precipitated by methylene blue is an underrecognized side effect that can be observed in individuals both with and without G6PD deficiency.</p>","PeriodicalId":47429,"journal":{"name":"Clinical Medicine & Research","volume":"23 1","pages":"21-25"},"PeriodicalIF":1.2,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12172662/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144318318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical Medicine & Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1